http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2163121-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afd3bfaf40bfd0dfab311c31f1724e74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2564167d73ca17828994ddd2fa307b9e
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
filingDate 2000-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2001-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df530da4e79b894a13ec39d14c687729
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3330485a6d4bcf5014ccb32e559f67b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be503e0475e9e08f98a5372496ff1bf7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_711fffb1c712b071c6430ee278d83969
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65613c3f41b4865e71c409d02603558f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad9b4a1e01a5524552c9fbdeb5c655a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7feed2baa02cc77fad72960a7fa3494e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_febf85d1e281f2897a0e85ab06758ea1
publicationDate 2001-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2163121-C1
titleOfInvention Anticold agent
abstract FIELD: medicine, pharmaceutical industry. SUBSTANCE: invention relates to a mixture of active components and medicinal form based on their that can be used for treatment of patients with cold sicknesses. Proposed agent is a mixture of codeine phosphate, caffeine, hexamethylenetetramine taken in the definite ratio of components. Invention provides preparing the preparation that shows the expressed antiviral activity and can be used in influenza epidemy. Also, claimed agent shows anticough effect. EFFECT: enhanced effectiveness of cold sicknesses treatment, decreased treatment time. 3 cl
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105476998-A
priorityDate 2000-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6321303
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2519
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501369
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419509525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419548960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448487131
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4101

Total number of triples: 33.